245 related articles for article (PubMed ID: 31619067)
1. Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma.
Palmieri M; Sarmento DJS; Falcão AP; Martins VAO; Brandão TB; Morais-Faria K; Ribeiro ACP; Hasséus B; Giglio D; Braz-Silva PH
Ear Nose Throat J; 2021 Sep; 100(5_suppl):449S-455S. PubMed ID: 31619067
[TBL] [Abstract][Full Text] [Related]
2. Oral complications of head and neck radiotherapy: prevalence and management.
Germano F; Melone P; Testi D; Arcuri L; Marmiroli L; Petrone A; Arcuri C
Minerva Stomatol; 2015 Aug; 64(4):189-202. PubMed ID: 25937580
[TBL] [Abstract][Full Text] [Related]
3. The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review.
Bressan V; Stevanin S; Bianchi M; Aleo G; Bagnasco A; Sasso L
Cancer Treat Rev; 2016 Apr; 45():105-19. PubMed ID: 27010487
[TBL] [Abstract][Full Text] [Related]
4. Dysphagia and Oral Morbidities in Chemoradiation-Treated Head and Neck Cancer Patients.
Ihara Y; Crary MA; Madhavan A; Gregorio DC; Im I; Ross SE; Carnaby GD
Dysphagia; 2018 Dec; 33(6):739-748. PubMed ID: 29619560
[TBL] [Abstract][Full Text] [Related]
5. Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Minhas S; Sajjad A; Chaudhry RM; Zahid H; Shahid A; Kashif M
Turk J Med Sci; 2021 Apr; 51(2):675-684. PubMed ID: 33155791
[TBL] [Abstract][Full Text] [Related]
6. [Impact of neck dissection in N2-3 oropharyngeal squamous cell carcinomas treated with definitive chemoradiotherapy: An observational real-life study].
Klausner G; Troussier I; Kreps S; Fabiano E; Laccourreye O; Giraud P
Cancer Radiother; 2021 Dec; 25(8):771-778. PubMed ID: 34175226
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
[TBL] [Abstract][Full Text] [Related]
8. Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia.
Yahya N; Linge A; Leger K; Maile T; Kemper M; Haim D; Jöhrens K; Troost EGC; Krause M; Löck S
Acta Oncol; 2022 Jul; 61(7):856-863. PubMed ID: 35657056
[TBL] [Abstract][Full Text] [Related]
9. Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
van der Laan HP; Bijl HP; Steenbakkers RJ; van der Schaaf A; Chouvalova O; Vemer-van den Hoek JG; Gawryszuk A; van der Laan BF; Oosting SF; Roodenburg JL; Wopken K; Langendijk JA
Radiother Oncol; 2015 Apr; 115(1):56-62. PubMed ID: 25792467
[TBL] [Abstract][Full Text] [Related]
10. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
[TBL] [Abstract][Full Text] [Related]
11. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment.
Gaetti-Jardim E; Jardim ECG; Schweitzer CM; da Silva JCL; Oliveira MM; Masocatto DC; Dos Santos CM
Arch Oral Biol; 2018 Jun; 90():45-52. PubMed ID: 29533791
[TBL] [Abstract][Full Text] [Related]
12. Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.
Buchapudi RR; Manickam R; M R AK; C R TP; Chandraraj V; Pyakuryal A; Narayanasamy G
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2463-2470. PubMed ID: 31450921
[TBL] [Abstract][Full Text] [Related]
13. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
14. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
15. Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Mollnar S; Pondorfer P; Kasparek AK; Reinisch S; Moik F; Stotz M; Halm M; Szkandera J; Terbuch A; Eisner F; Gerger A; Kapp KS; Partl R; Vasicek S; Weiland T; Pichler M; Stöger H; Thurnher D; Posch F
Clin Transl Oncol; 2021 Mar; 23(3):543-553. PubMed ID: 32671728
[TBL] [Abstract][Full Text] [Related]
16. Treatment-related dysgeusia in head and neck cancer patients.
Irune E; Dwivedi RC; Nutting CM; Harrington KJ
Cancer Treat Rev; 2014 Oct; 40(9):1106-17. PubMed ID: 25064135
[TBL] [Abstract][Full Text] [Related]
17. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Carboplatin/Paclitaxel-Based Radiochemotherapy in Locally Advanced Squamous Cell Carcinoma of Head and Neck.
Maring S; Elsayad K; Stenner M; Rudack C; Haverkamp U; Rehkämper J; Wardelmann E; Eich HT
Oncol Res Treat; 2018; 41(12):736-743. PubMed ID: 30419553
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients.
Mercadante S; Aielli F; Adile C; Ferrera P; Valle A; Fusco F; Caruselli A; Cartoni C; Massimo P; Masedu F; Valenti M; Porzio G
Support Care Cancer; 2015 Nov; 23(11):3249-55. PubMed ID: 25832897
[TBL] [Abstract][Full Text] [Related]
20. Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
Sayed R; El Wakeel L; Saad AS; Kelany M; El-Hamamsy M
Med Oncol; 2019 Nov; 37(1):8. PubMed ID: 31748905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
